相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals
Bin Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes
Chao Yu et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2019)
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Reenam S. Khan et al.
HEPATOLOGY (2019)
Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials
Elizabeth M. Brunt et al.
HEPATOLOGY (2019)
Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non-alcoholic fatty liver disease
Kenichi Tanaka et al.
HEPATOLOGY RESEARCH (2019)
Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!
Golnaz Ranjbar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease
Keisuke Kakisaka et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Nonalcoholic Steatofibrosis Independently Predicts Mortality in Nonalcoholic Fatty Liver Disease
Zobair M. Younossi et al.
HEPATOLOGY COMMUNICATIONS (2017)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis
James A. Thomas et al.
ANNALS OF INTERNAL MEDICINE (2017)
Nonalcoholic Fatty Liver Disease The New Complication of Type 2 Diabetes Mellitus
Fernando Bril et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
Epidemiology and natural history of non-alcoholic fatty liver disease
Yousef Fazel et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
Paola Portillo-Sanchez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2015)
Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients
Takashi Nakahara et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Maria Stepanova et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
Raluca Pais et al.
JOURNAL OF HEPATOLOGY (2013)
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
Chenggang Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Group-Based Trajectory Modeling in Clinical Research
Daniel S. Nagin et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 6 (2010)
Histological Course of Nonalcoholic Fatty Liver Disease in Japanese Patients - Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis
Erika Hamaguchi et al.
DIABETES CARE (2010)
Clinical, Laboratory and Histological Associations in Adults with Nonalcoholic Fatty Liver Disease
Brent A. Nettschwander-Tetri et al.
HEPATOLOGY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Portal Chronic Inflammation in Nonalcoholic Fatty Liver Disease (NAFLD): A Histologic Marker of Advanced NAFLD-Clinicopathologic Correlations from the Nonalcoholic Steatohepatitis Clinical Research Network
Elizabeth M. Brunt et al.
HEPATOLOGY (2009)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH
Y Yoshioka et al.
JOURNAL OF GASTROENTEROLOGY (2004)
A SAS procedure based on mixture models for estimating developmental trajectories
BL Jones et al.
SOCIOLOGICAL METHODS & RESEARCH (2001)
分享论文
